[ad_1]
Two pharmaceutical companies have revealed two effective new treatments that are good news for Corona patients.
The company “Regeneron” recently declared that a drug developed in the laboratory using so-called monoclonal antibodies may be effective in the treatment of “Covid 19” disease, which is caused by the emerging corona virus.
She explained that the combination of antibodies appears to be effective in treating the two mutated Corona strains that have appeared in Britain and South Africa.
Scientists from “Regeneron” and New York University in New York said the experiments confirmed the effectiveness of these antibodies in eliminating both strains.
These results are still at a preliminary stage, but they could help in the future to cope with the mutations that appear in the Corona virus and have become a major health problem, according to Sky News.
These antibodies have not been tested on the strain that appeared in Brazil, but the researchers suggest that the drug will be effective in neutralizing it, as well as in reducing the number of deaths from the disease.
On a related note, the company “Eli Lilly” said that by mixing it between two antibodies, it showed efficacy in people with Corona who were most likely to suffer from severe symptoms.
She explained that the treatment was able to reduce the likelihood of hospitalization in these patients by 70 percent, and this question was confirmed by the results of the last stage of clinical trials.
She said this treatment can protect the person with corona from symptoms and can also stop the infection from spreading in nursing homes.
The drugs Regeneron and Eli Lilly have received approval from the United States Food and Drug Administration for emergency use in the treatment of symptoms of the emerging corona virus.
Follow the health statement via Google News
Source link
